Viewing Study NCT05732402


Ignite Creation Date: 2025-12-25 @ 3:39 AM
Ignite Modification Date: 2026-05-28 @ 9:15 AM
Study NCT ID: NCT05732402
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-14
First Post: 2023-02-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases
Sponsor: Alpine Immune Sciences, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lupus Nephritis View
None Immunoglobulin A Nephropathy View
None Membranous Nephropathy View
None Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None IgA nephropathy View
None glomerulonephritis, IgA View
None Immunoglobulin A nephropathy View
None Berger disease View
None lupus nephritis View
None lupus glomerulonephritides View
None primary membranous nephropathy View
None membranous nephropathy View
None glomerulonephritis, membranous View
None PLA2R View
None THSD7A View
None ALPN-303 View
None povetacicept View
None RUBY-3 View
None RUBY3 View
None Gd-IgA1 View
None GdIgA1 View
None anti-neutrophil cytoplasmic antibody associated vasculitis View
None ANCA Vasculitis View
None AAV View
None Microscopic polyangiitis View
None Granulomatosis with polyangiitis View
None Eosinophilic granulomatosis with polyangiitis View
None Wegener's granulomatosis View
None Churg-Strauss Disease View
None Myeloperoxidase (MPO) View
None Proteinase 3 (PR3) View